Combined treatment of alendronate and low-intensity pulsed ultrasound (LIPUS) increases bone mineral density at the cancellous bone osteotomy site in aged rats: a preliminary study

JNMA J Nepal Med Assoc. 2011 Oct-Dec;51(184):171-5.

Abstract

Introduction: During fracture healing, alendronate encourages callus volume by inhibiting bone resorption, whereas low-intensity pulsed ultrasound (LIPUS) enhances bone regeneration by promoting an anabolic response.

Methods: In the present study, 9-month-old Sprague-Dawley rats, with a unilateral proximal tibial osteotomy, were treated with alendronate (daily, 1 µg/kg) plus sham-LIPUS (n = 14), saline plus LIPUS (20 min/day) (n = 18), alendronate plus LIPUS (n = 16), or saline plus sham-LIPUS as a control (n = 13) for 4 weeks. The rats were then examined for changes in bone mineral density (BMD) during metaphyseal bone repair.

Results: The combined therapy significantly increased BMD at the osteotomy site at 4 weeks (p < 0.001) compared with the control, without affecting the contralateral, non-osteotomized tibia. Both alendronate and LIPUS alone also exerted a positive, albeit less, effect on BMD in the affected limb (p < 0.001 and p = 0.006, respectively).

Conclusion: Alendronate and LIPUS cooperate to enhance BMD during metaphyseal bone healing.

Publication types

  • Comparative Study

MeSH terms

  • Alendronate / therapeutic use*
  • Animals
  • Bone Density Conservation Agents / therapeutic use
  • Bone Density*
  • Bone Regeneration*
  • Bony Callus*
  • Disease Models, Animal
  • Female
  • Osteotomy*
  • Rats
  • Rats, Sprague-Dawley
  • Tibia / diagnostic imaging
  • Tibia / drug effects
  • Tibia / surgery
  • Ultrasonic Therapy / methods*
  • Ultrasonography

Substances

  • Bone Density Conservation Agents
  • Alendronate